- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
FINN Partners and Hyderus Unite for Global Health Communications and Policy Practice
Move enables FINN to address pressing health priorities in developed and developing nations and expands Hyderus global service capabilities and client offerings and Hyderus co-founders Mark Chataway and Christopher Nial join FINN global health leaders team.
Global independent marketing and communications agency FINN Partners has announced that Hyderus, an international health-focused communications and policy firm, is joining FINN. Co-founders Mark Chataway and Christopher Nial will lead FINN's Global Health Practice and co-lead its EMEA Public Health Group. Hyderus is known for its global work in public health, health policy strategy, drug development and marketing communications, risk perception and crisis management.
The agency will now be branded "Hyderus, a FINN Partners Company." The merger increases FINN's total staff to more than 1,400 employees, with more than 275 professionals worldwide dedicated to the health sector.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
